Factors Influencing the Visual Acuity of Chronic Central Serous Chorioretinopathy
Authors:
Open Access
- 1 January 2011
- journal article
- research article
- Published by Korean Ophthalmological Society in Korean Journal of Ophthalmology
- Vol. 25 (2) , 90-97
Abstract
Kim YY, et al. Korean J Ophthalmol. 2011 Apr;25(2):90-97. https://doi.org/10.3341/kjo.2011.25.2.90Keywords
This publication has 42 references indexed in Scilit:
- Alterations of retinal pigment epithelium in central serous chorioretinopathyClinical & Experimental Ophthalmology, 2007
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyBritish Journal of Ophthalmology, 2006
- Clinical characteristics of subretinal deposits in central serous chorioretinopathyActa Ophthalmologica Scandinavica, 2005
- Optical coherence tomography characterisation of idiopathic central serous chorioretinopathyBritish Journal of Ophthalmology, 2005
- BDNF Reduces the Retinal Toxicity of Verteporfin Photodynamic TherapyInvestigative Ophthalmology & Visual Science, 2004
- Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathyEye, 2004
- CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2003
- Cone Photoreceptor Recovery after Experimental Detachment and Reattachment: An Immunocytochemical, Morphological, and Electrophysiological StudyInvestigative Ophthalmology & Visual Science, 2003
- Problems with and pitfalls of photodynamic therapy 1 1The authors have no proprietary interest in this product.Ophthalmology, 2000
- Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey11The Massachusetts Eye and Ear Infirmary is an owner of a patent covering the use of verteporfin and photodynamic therapy. Should the Massachusetts Eye and Ear Infirmary receive royalties or other financial remuneration related to that patent, Drs. Miller and Gragoudas would receive a share of same in accordance with the Massachusetts Eye and Ear Infirmary’s institutional Patent Policy and Procedures, which includes royalty-sharing provisions. As faculty members of the Harvard Medical School, they also adhere to their general Faculty Policies on Integrity in Science, which govern research and conflict of interest issues.Ophthalmology, 1999